Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.22 trillion and total revenue of $123.27 billion.
Market Cap
1.22T
Revenue
123.27B
Profits
-34.12B
PE Ratio
n/a
Profit Margin
-27.68%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.58B | -1.08% | 1,747,650 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 92.39B | -0.19% | 880,216 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 78.90B | -2.17% | 9,697,804 | 2.53B |
| 4 | ARGX | argenx SE | 58.56B | -1.73% | 249,733 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 44.66B | -2.19% | 356,971 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 39.26B | 1.08% | 3,531,606 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 34.87B | 1.11% | 4,741,920 | 197.56M |
| 8 | GMAB | Genmab A/S | 32.26B | -1.46% | 2,899,118 | 4.30B |
| 9 | INSM | Insmed Incorporated | 31.01B | -2.17% | 6,215,878 | 1.52B |
| 10 | ROIV | Roivant Sciences Ltd. | 28.01B | -0.78% | 3,970,072 | 41.08M |
| 11 | INCY | Incyte Corporation | 23.36B | -1.07% | 1,537,177 | 6.01B |
| 12 | BNTX | BioNTech SE | 20.07B | -0.52% | 1,710,253 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 19.26B | -2.71% | 2,331,677 | 5.01B |
| 14 | ASND | Ascendis Pharma A/S | 16.58B | -1.26% | 602,891 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 15.77B | -1.82% | 2,194,229 | 2.50B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.81B | -2.75% | 1,478,672 | 945.54M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 14.78B | -2.62% | 984,644 | 4.72B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.70B | -1.64% | 6,062,667 | 3.66B |
| 19 | TECH | Bio-Techne Corporation | 11.42B | -0.04% | 3,663,183 | 1.23B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 10.41B | -1.82% | 1,502,744 | 1.80B |
| 21 | KYMR | Kymera Therapeutics, Inc. | 9.84B | -3.42% | 1,278,323 | 102.24M |
| 22 | KRYS | Krystal Biotech, Inc. | 9.15B | -2.19% | 286,699 | 470.03M |
| 23 | SYRE | Spyre Therapeutics, Inc. | 8.88B | -4.26% | 805,362 | - |
| 24 | TGTX | TG Therapeutics, Inc. | 8.87B | -2.37% | 2,089,093 | 897.76M |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 8.81B | -4.45% | 327,824 | 1.43B |
| 26 | PCVX | Vaxcyte, Inc. | 8.77B | -5.09% | 1,912,018 | - |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.40B | -3.37% | 806,162 | 7.46M |
| 28 | SMMT | Summit Therapeutics Inc. | 7.96B | -5.87% | 7,220,139 | - |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 7.92B | -2.11% | 600,710 | 551.69M |
| 30 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.79B | -3.80% | 1,502,462 | 280.75M |
| 31 | CGON | CG Oncology, Inc. | 7.10B | -2.97% | 1,673,717 | 6.17M |
| 32 | CYTK | Cytokinetics, Incorporated | 7.07B | -1.32% | 1,429,671 | 113.29M |
| 33 | TWST | Twist Bioscience Corporation | 7.04B | -7.44% | 3,379,920 | 459.43M |
| 34 | CORT | Corcept Therapeutics Incorporated | 6.96B | -2.09% | 1,091,120 | 963.65M |
| 35 | AXSM | Axsome Therapeutics, Inc. | 6.80B | -4.66% | 770,156 | 865.27M |
| 36 | IMVT | Immunovant, Inc. | 6.57B | -2.31% | 704,929 | - |
| 37 | ORKA | Oruka Therapeutics, Inc. | 6.50B | -1.80% | 1,977,019 | - |
| 38 | IBRX | ImmunityBio, Inc. | 6.40B | -8.37% | 10,641,767 | 182.57M |
| 39 | KOD | Kodiak Sciences Inc. | 6.34B | -0.75% | 693,120 | - |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | 0.65% | 1,062,251 | 670.78M |
| 41 | ABVX | ABIVAX Société Anonyme | 6.03B | -9.24% | 14,852,919 | 5.33M |
| 42 | SRRK | Scholar Rock Holding Corporation | 5.87B | -4.45% | 2,076,166 | 570.00K |
| 43 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.85B | -5.22% | 3,906,185 | 450.82M |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -0.03% | 259,757 | 253.83M |
| 45 | BLTE | Belite Bio, Inc | 5.17B | -15.65% | 1,038,037 | - |
| 46 | MANE | Veradermics, Incorporated | 5.04B | -3.92% | 374,990 | - |
| 47 | CAI | Caris Life Sciences, Inc. | 5.04B | -5.18% | 4,568,174 | 1.05B |
| 48 | ERAS | Erasca, Inc. | 4.78B | -4.29% | 11,073,349 | - |
| 49 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | -0.33% | 799,661 | 2.72M |
| 50 | PTCT | PTC Therapeutics, Inc. | 4.71B | -3.27% | 952,598 | 1.16B |
| 51 | COGT | Cogent Biosciences, Inc. | 4.65B | -3.70% | 2,128,424 | - |
| 52 | TVTX | Travere Therapeutics, Inc. | 4.51B | -2.69% | 1,329,567 | 651.03M |
| 53 | IONS | Ionis Pharmaceuticals, Inc. | 4.43B | -2.35% | 3,185,935 | 960.09M |
| 54 | EWTX | Edgewise Therapeutics, Inc. | 4.37B | -3.07% | 1,186,702 | - |
| 55 | DFTX | Definium Therapeutics, Inc. | 3.88B | -3.87% | 3,238,016 | - |
| 56 | CRSP | CRISPR Therapeutics AG | 3.79B | 0.44% | 3,322,561 | 25.17M |
| 57 | TNGX | Tango Therapeutics, Inc. | 3.68B | -4.32% | 1,740,729 | 53.81M |
| 58 | XENE | Xenon Pharmaceuticals Inc. | 3.64B | -1.38% | 1,090,782 | 7.50M |
| 59 | TARS | Tarsus Pharmaceuticals, Inc. | 3.60B | -6.00% | 706,751 | 682.20M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.56B | 1.32% | 3,974,821 | 10.35M |
| 61 | PBLS | Parabilis Medicines, Inc. | 3.44B | -0.69% | 1,246,541 | 2.26M |
| 62 | ELVN | Enliven Therapeutics, Inc. | 3.42B | 0.26% | 933,555 | - |
| 63 | IRON | Disc Medicine, Inc. | 3.42B | -1.27% | 561,636 | - |
| 64 | VRDN | Viridian Therapeutics, Inc. | 3.40B | -4.71% | 1,747,926 | 26.31M |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | -2.98% | 1,290,169 | 508.68M |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.19B | -5.61% | 13,732,083 | 378.98M |
| 67 | ABCL | AbCellera Biologics Inc. | 3.16B | -7.45% | 4,247,358 | 67.85M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.16B | -4.14% | 3,653,951 | - |
| 69 | LEGN | Legend Biotech Corporation | 2.96B | -5.28% | 3,422,836 | 1.36B |
| 70 | DNLI | Denali Therapeutics Inc. | 2.96B | 1.37% | 2,632,241 | 21.38M |
| 71 | ACAD | Acadia Pharmaceuticals Inc. | 2.96B | -2.73% | 1,903,306 | 1.20B |
| 72 | VCEL | Vericel Corporation | 2.94B | -1.27% | 582,337 | 324.17M |
| 73 | ADMA | ADMA Biologics, Inc. | 2.92B | -1.27% | 2,448,064 | 519.15M |
| 74 | TLX | Telix Pharmaceuticals Limited | 2.92B | -3.90% | 269,404 | 890.79M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.90B | -3.31% | 2,231,064 | - |
| 76 | SLS | SELLAS Life Sciences Group, Inc. | 2.78B | -8.08% | 15,482,378 | - |
| 77 | CELC | Celcuity Inc. | 2.62B | -5.26% | 633,993 | - |
| 78 | XNCR | Xencor, Inc. | 2.50B | -2.21% | 1,220,573 | 200.49M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -2.33% | 1,113,897 | 36.54M |
| 80 | MBX | MBX Biosciences, Inc. | 2.46B | -7.23% | 581,885 | - |
| 81 | ZLAB | Zai Lab Limited | 2.36B | -4.06% | 1,442,193 | 441.73M |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.25B | -1.01% | 1,673,536 | 100.00M |
| 83 | PHVS | Pharvaris N.V. | 2.21B | -1.20% | 463,996 | - |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.21B | -5.64% | 1,744,837 | 25.94M |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.15B | -1.93% | 1,715,751 | 158.00K |
| 86 | LKFT | Lakefront Biotherapeutics NV | 2.14B | -0.24% | 162,486 | 1.13B |
| 87 | PVLA | Palvella Therapeutics, Inc. | 2.09B | -2.00% | 192,667 | - |
| 88 | BEAM | Beam Therapeutics Inc. | 2.08B | -0.19% | 3,886,508 | 146.64M |
| 89 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -1.28% | 1,341,412 | 321.74M |
| 90 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | -1.18% | 582,620 | 989.36M |
| 91 | LYCA | Lycia Therapeutics, Inc. | 1.91B | 4.09% | 422,136 | 4.44M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 1.90B | -2.70% | 2,072,101 | - |
| 93 | BHVN | Biohaven Ltd. | 1.87B | -9.23% | 2,394,680 | - |
| 94 | IMNM | Immunome, Inc. | 1.85B | -5.54% | 1,056,097 | 4.02M |
| 95 | VERA | Vera Therapeutics, Inc. | 1.84B | -4.86% | 1,372,403 | 10.28M |
| 96 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | -1.43% | 347,014 | - |
| 97 | SEPN | Septerna, Inc. | 1.84B | -1.51% | 374,237 | 96.27M |
| 98 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | -2.92% | 1,785,365 | 213.00M |
| 99 | REPL | Replimune Group, Inc. | 1.81B | -0.83% | 1,964,451 | - |
| 100 | ZYME | Zymeworks Inc. | 1.80B | -2.68% | 738,811 | 265.97M |
| 101 | FTRE | Fortrea Holdings Inc. | 1.79B | -7.94% | 1,542,110 | 2.67B |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.75B | -0.45% | 615,748 | 28.21M |
| 103 | TRAX | First Tracks Biotherapeutics, Inc. | 1.75B | -6.34% | 504,327 | - |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.72B | -3.27% | 818,927 | 20.00M |
| 105 | KRSA | Korsana Biosciences, Inc. | 1.71B | 5.95% | 265,233 | - |
| 106 | RARE | Ultragenyx Pharmaceutical Inc. | 1.67B | -4.30% | 3,010,190 | 730.00M |
| 107 | BRVE | Braveheart Bio, Inc. | 1.66B | 5.81% | 866,495 | - |
| 108 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | -4.03% | 776,163 | 140.84M |
| 109 | ZBIO | Zenas BioPharma, Inc. | 1.62B | -4.75% | 579,893 | 11.00M |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.53B | -9.93% | 29,877,224 | 68.23M |
| 111 | PGEN | Precigen, Inc. | 1.51B | 1.20% | 6,069,718 | 156.94M |
| 112 | MESO | Mesoblast Limited | 1.46B | -2.59% | 192,701 | 120.25M |
| 113 | DMRA | Damora Therapeutics, Inc. | 1.44B | -4.44% | 643,366 | - |
| 114 | VIR | Vir Biotechnology, Inc. | 1.44B | -5.41% | 3,089,841 | 302.80M |
| 115 | KLRA | Kailera Therapeutics, Inc. | 1.43B | -4.84% | 553,329 | - |
| 116 | SRPT | Sarepta Therapeutics, Inc. | 1.43B | -5.93% | 2,253,865 | 1.96B |
| 117 | ADRX | ADARx Pharmaceuticals, Inc. | 1.42B | -9.68% | 708,674 | 6.79M |
| 118 | WWB | Windward Bio Group AG | 1.41B | 1.15% | 158,586 | - |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.40B | -5.51% | 2,433,656 | 701.94M |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.40B | 5.04% | 15,194,229 | 52.89M |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.39B | 1.98% | 467,576 | - |
| 122 | ANAB | AnaptysBio, Inc. | 1.39B | -1.62% | 432,444 | 60.04M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.37B | -1.82% | 437,695 | 20.00M |
| 124 | IMCR | Immunocore Holdings plc | 1.36B | -0.83% | 546,182 | 429.30M |
| 125 | NBTX | Nanobiotix S.A. | 1.36B | -3.00% | 125,283 | 13.15M |
| 126 | QURE | uniQure N.V. | 1.36B | -4.35% | 2,104,181 | 20.17M |
| 127 | URGN | UroGen Pharma Ltd. | 1.36B | -12.86% | 2,399,079 | 250.25M |
| 128 | NUVB | Nuvation Bio Inc. | 1.34B | -0.26% | 6,848,900 | 201.73M |
| 129 | INVA | Innoviva, Inc. | 1.31B | 0.00% | 1,146,539 | 438.32M |
| 130 | ABSI | Absci Corporation | 1.30B | -7.97% | 4,747,312 | 1.49M |
| 131 | AVLN | Avalyn Pharma Inc. | 1.26B | -1.05% | 214,298 | - |
| 132 | LBRX | LB Pharmaceuticals Inc | 1.26B | -2.97% | 303,055 | - |
| 133 | MNKD | MannKind Corporation | 1.24B | -2.53% | 4,178,914 | 413.37M |
| 134 | NVAX | Novavax, Inc. | 1.23B | -3.24% | 4,735,225 | 411.65M |
| 135 | SLN | Silence Therapeutics plc | 1.23B | 0.00% | 399,144 | 456.00K |
| 136 | GENB | Generate Biomedicines, Inc. | 1.23B | -8.00% | 967,855 | 21.07M |
| 137 | OCUL | Ocular Therapeutix, Inc. | 1.23B | -4.95% | 2,895,412 | 50.38M |
| 138 | TSHA | Taysha Gene Therapies, Inc. | 1.21B | -1.33% | 3,150,764 | 5.49M |
| 139 | MLYS | Mineralys Therapeutics, Inc. | 1.21B | -3.53% | 1,345,606 | - |
| 140 | GHRS | GH Research PLC | 1.20B | -5.55% | 298,805 | - |
| 141 | VOR | Vor Biopharma Inc. | 1.18B | 3.62% | 1,555,129 | - |
| 142 | GPCR | Structure Therapeutics Inc. | 1.15B | -5.78% | 786,228 | - |
| 143 | SVRA | Savara Inc. | 1.15B | -18.23% | 17,083,772 | - |
| 144 | AAPG | Ascentage Pharma Group International | 1.10B | -3.78% | 5,039 | 94.61M |
| 145 | DRTS | Alpha Tau Medical Ltd. | 1.09B | 3.93% | 628,875 | - |
| 146 | KARD | Kardigan, Inc. | 1.08B | -7.83% | 459,244 | - |
| 147 | JBIO | Jade Biosciences, Inc. | 1.06B | 1.66% | 1,021,381 | - |
| 148 | NKTR | Nektar Therapeutics | 1.03B | -7.19% | 1,017,697 | 52.19M |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.02B | -7.21% | 252,126 | 2.00M |
| 150 | SGP | SpyGlass Pharma, Inc. | 1.02B | -1.14% | 108,907 | - |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.02B | -4.30% | 522,538 | - |
| 152 | OMER | Omeros Corporation | 983.66M | -5.71% | 2,019,784 | 74.36M |
| 153 | SPTX | Seaport Therapeutics, Inc. | 966.23M | -1.47% | 284,271 | - |
| 154 | CTY | City Therapeutics, Inc. | 961.30M | 5.29% | 250,121 | 14.34M |
| 155 | MLTX | MoonLake Immunotherapeutics | 942.13M | 0.36% | 1,694,554 | - |
| 156 | AKTS | Aktis Oncology, Inc. | 901.14M | -1.52% | 374,943 | 12.39M |
| 157 | IMTX | Immatics N.V. | 878.58M | -3.03% | 746,739 | 49.33M |
| 158 | LTGO | Latigo Biotherapeutics, Inc. | 861.89M | -1.81% | 267,166 | - |
| 159 | PHAR | Pharming Group N.V. | 840.43M | -5.18% | 10,505 | 386.75M |
| 160 | CRVS | Corvus Pharmaceuticals, Inc. | 815.69M | -3.40% | 927,500 | - |
| 161 | BBTX | Bambusa Therapeutics, Inc. | 815.08M | 2.89% | 137,667 | - |
| 162 | ODTX | Odyssey Therapeutics, Inc. | 813.08M | -7.52% | 677,842 | 99.00K |
| 163 | VSTM | Verastem, Inc. | 797.67M | -7.73% | 3,248,798 | 100.30M |
| 164 | SNDX | Syndax Pharmaceuticals, Inc. | 785.05M | -4.49% | 2,182,538 | 289.68M |
| 165 | MGTX | MeiraGTx Holdings plc | 779.89M | -1.97% | 1,013,977 | 401.91M |
| 166 | MTRI | Mentari Therapeutics, Inc. | 776.36M | -3.61% | 85,123 | - |
| 167 | ORIC | ORIC Pharmaceuticals, Inc. | 764.94M | -4.42% | 1,455,496 | - |
| 168 | IVA | Inventiva S.A. | 761.40M | -8.99% | 3,023,100 | 2.81M |
| 169 | RIGL | Rigel Pharmaceuticals, Inc. | 754.89M | -2.67% | 352,228 | 288.21M |
| 170 | ARDX | Ardelyx, Inc. | 751.60M | -2.29% | 6,201,119 | 468.22M |
| 171 | OBX | Obsidian Therapeutics, Inc. | 741.27M | -1.23% | 336,484 | - |
| 172 | GLUE | Monte Rosa Therapeutics, Inc. | 738.29M | -3.03% | 2,520,421 | 70.33M |
| 173 | AURA | Aura Biosciences, Inc. | 714.99M | -1.58% | 791,132 | - |
| 174 | SLDB | Solid Biosciences Inc. | 697.57M | -2.95% | 1,558,939 | - |
| 175 | ATTO | Attovia Therapeutics, Inc. | 690.26M | -3.08% | 372,219 | 1.44M |
| 176 | LXRX | Lexicon Pharmaceuticals, Inc. | 681.21M | -8.38% | 4,205,942 | 38.54M |
| 177 | OABI | OmniAb, Inc. | 679.71M | -7.36% | 1,898,284 | 40.21M |
| 178 | APMD | Apnimed, Inc. | 669.84M | -6.72% | 248,546 | 108.80M |
| 179 | NVCT | Nuvectis Pharma, Inc. | 666.80M | -2.27% | 301,603 | - |
| 180 | SGMT | Sagimet Biosciences Inc. | 648.02M | -5.61% | 1,501,037 | - |
| 181 | KURA | Kura Oncology, Inc. | 634.88M | -5.99% | 1,752,373 | 79.31M |
| 182 | PRME | Prime Medicine, Inc. | 633.49M | -7.55% | 6,134,377 | 7.06M |
| 183 | IAM | Iambic Therapeutics, Inc. | 621.42M | -8.06% | 285,256 | 24.91M |
| 184 | JANX | Janux Therapeutics, Inc. | 616.73M | -2.04% | 1,114,707 | 23.29M |
| 185 | ABUS | Arbutus Biopharma Corporation | 616.24M | -1.23% | 2,993,383 | 181.49M |
| 186 | OLMA | Olema Oncology, Inc. | 615.00M | -1.82% | 1,256,468 | - |
| 187 | QUIT | Achieve Life Sciences, Inc. | 611.79M | -5.28% | 1,926,847 | - |
| 188 | ANNX | Annexon, Inc. | 591.37M | -9.09% | 4,457,145 | - |
| 189 | IMMX | Immix Biopharma, Inc. | 583.33M | -1.14% | 1,572,776 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 577.61M | -3.22% | 281,931 | - |
| 191 | CGEM | Cullinan Therapeutics, Inc. | 577.15M | -1.98% | 1,010,538 | - |
| 192 | FDMT | 4D Molecular Therapeutics, Inc. | 576.76M | -4.57% | 690,939 | 96.06M |
| 193 | ENTX | Entera Bio Ltd. | 575.53M | 0.76% | 469,047 | 42.00K |
| 194 | DBVT | DBV Technologies S.A. | 571.97M | -4.25% | 156,494 | 3.74M |
| 195 | GERN | Geron Corporation | 560.94M | -4.63% | 13,833,298 | 217.52M |
| 196 | BCAX | Bicara Therapeutics Inc. | 560.31M | -7.46% | 814,505 | - |
| 197 | CBIO | Crescent Biopharma, Inc. | 556.41M | 0.70% | 422,370 | 15.00M |
| 198 | ANL | Adlai Nortye Group Ltd. | 550.60M | -5.63% | 380,645 | 18.06M |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 545.63M | -1.71% | 2,187,514 | 6.40M |
| 200 | AVBP | ArriVent BioPharma, Inc. | 544.13M | -6.57% | 1,053,365 | 5.00M |
| 201 | SRZN | Surrozen, Inc. | 542.49M | -7.21% | 148,847 | 10.53M |
| 202 | CLYM | Climb Bio, Inc. | 539.80M | -0.97% | 770,168 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 521.26M | -3.42% | 1,152,979 | 147.76M |
| 204 | OBIO | Orchestra BioMed Holdings, Inc. | 517.88M | -6.00% | 554,263 | 31.21M |
| 205 | ALMS | Alumis Inc. | 514.09M | -8.55% | 1,794,569 | 7.24M |
| 206 | ETRA | Electra Therapeutics, Inc. | 509.04M | -9.28% | 376,121 | - |
| 207 | WVE | Wave Life Sciences, Inc. | 504.91M | -5.88% | 2,283,405 | 70.92M |
| 208 | VALN | Valneva SE | 493.60M | -3.91% | 17,550 | 163.30M |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 483.54M | -9.02% | 2,510,975 | 130.75M |
| 210 | SANA | Sana Biotechnology, Inc. | 476.42M | -8.62% | 4,458,957 | - |
| 211 | RGNX | REGENXBIO Inc. | 473.44M | -0.28% | 1,062,394 | 153.91M |
| 212 | MNPR | Monopar Therapeutics Inc. | 467.60M | -1.84% | 132,610 | - |
| 213 | FENC | Fennec Pharmaceuticals Inc. | 462.14M | -2.68% | 398,244 | 66.37M |
| 214 | GYRE | Gyre Therapeutics, Inc. | 460.79M | -6.86% | 240,135 | 110.06M |
| 215 | NGNE | Neurogene Inc. | 458.53M | -3.40% | 178,263 | 925.00K |
| 216 | BLSM | BlossomHill Therapeutics, Inc. | 458.29M | 0.69% | 270,735 | - |
| 217 | ASMB | Assembly Biosciences, Inc. | 454.39M | -1.38% | 480,919 | 67.01M |
| 218 | STTK | Shattuck Labs, Inc. | 454.22M | -1.98% | 1,031,180 | 1.00M |
| 219 | HELP | Helus Pharma Inc. | 446.40M | -9.88% | 2,505,237 | - |
| 220 | DMAC | DiaMedica Therapeutics Inc. | 445.15M | 2.87% | 313,542 | - |
| 221 | MDXG | MiMedx Group, Inc. | 445.07M | -1.93% | 2,120,137 | 303.73M |
| 222 | CTMX | CytomX Therapeutics, Inc. | 442.55M | -0.98% | 4,868,683 | 14.03M |
| 223 | CAPR | Capricor Therapeutics, Inc. | 441.30M | 0.80% | 20,056,476 | 11.13M |
| 224 | OCS | Oculis Holding AG | 435.83M | -5.11% | 235,174 | 1.12M |
| 225 | INDP | Indaptus Therapeutics, Inc. | 433.10M | -9.90% | 239,359 | - |
| 226 | IRLA | IRulya Therapeutics Inc. | 432.36M | -0.15% | 200,561 | - |
| 227 | ARVN | Arvinas, Inc. | 423.03M | -4.15% | 1,108,445 | 275.30M |
| 228 | PRTA | Prothena Corporation plc | 422.10M | -2.14% | 861,946 | 52.74M |
| 229 | CRMD | CorMedix Inc. | 419.16M | 3.74% | 3,609,755 | 412.49M |
| 230 | OVID | Ovid Therapeutics Inc. | 415.21M | -5.98% | 2,833,645 | 1.45M |
| 231 | RZLT | Rezolute, Inc. | 411.22M | -6.67% | 2,478,408 | - |
| 232 | TECX | Tectonic Therapeutic, Inc. | 405.26M | -1.47% | 268,769 | - |
| 233 | TVGN | Tevogen Inc. | 405.20M | -6.35% | 9,329 | - |
| 234 | CADL | Candel Therapeutics, Inc. | 395.37M | -1.75% | 1,727,102 | - |
| 235 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.72M | -5.23% | 361,642 | - |
| 236 | AVTX | Avalo Therapeutics, Inc. | 390.88M | 0.15% | 1,179,818 | 59.00K |
| 237 | IRD | Opus Genetics, Inc. | 385.65M | -2.21% | 1,187,138 | 7.91M |
| 238 | PHAT | Phathom Pharmaceuticals, Inc. | 378.82M | -8.27% | 1,330,402 | 274.88M |
| 239 | PBYI | Puma Biotechnology, Inc. | 364.47M | -0.98% | 861,208 | 231.83M |
| 240 | ASPE | Aspen Neuroscience, Inc. | 361.16M | 0.24% | 130,038 | - |
| 241 | ALEC | Alector, Inc. | 347.63M | 1.52% | 1,953,024 | 173.47M |
| 242 | YDES | YD Bio Limited | 342.12M | 5.92% | 29,790 | 1.24M |
| 243 | CTNM | Contineum Therapeutics, Inc. | 340.83M | -3.98% | 369,211 | - |
| 244 | LYEL | Lyell Immunopharma, Inc. | 339.28M | 1.62% | 171,085 | 15.00K |
| 245 | MPLT | MapLight Therapeutics, Inc. | 333.87M | -7.48% | 357,916 | - |
| 246 | PRLD | Prelude Therapeutics Incorporated | 333.54M | -0.77% | 300,079 | 21.57M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 330.12M | -2.48% | 1,707,224 | - |
| 248 | INO | Inovio Pharmaceuticals, Inc. | 329.66M | 2.92% | 7,920,895 | 298.90K |
| 249 | CCCC | C4 Therapeutics, Inc. | 325.67M | 1.64% | 3,628,833 | 32.28M |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 318.00M | 0.76% | 416,457 | - |
| 251 | PROK | ProKidney Corp. | 314.48M | -1.89% | 1,901,121 | 775.00K |
| 252 | SLBT | SL Science Holding Limited | 313.65M | -5.37% | 28,629 | 3.27M |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 306.34M | 1.35% | 1,825,295 | 16.96M |
| 254 | SPRY | ARS Pharmaceuticals, Inc. | 297.56M | -11.90% | 2,784,255 | 122.14M |
| 255 | EVMN | Evommune, Inc. | 291.10M | -2.76% | 549,398 | 10.00M |
| 256 | BNTC | Benitec Biopharma Inc. | 285.88M | -2.76% | 268,685 | - |
| 257 | GLSI | Greenwich LifeSciences, Inc. | 282.56M | -2.73% | 472,105 | - |
| 258 | DTIL | Precision BioSciences, Inc. | 282.46M | 7.09% | 429,792 | 45.04M |
| 259 | FULC | Fulcrum Therapeutics, Inc. | 281.85M | -0.54% | 2,159,794 | 80.00M |
| 260 | TRXB | TRex Bio, Inc. | 281.70M | 6.12% | 92,988 | - |
| 261 | RLMD | Relmada Therapeutics, Inc. | 279.54M | -15.76% | 2,249,760 | - |
| 262 | GALT | Galectin Therapeutics Inc. | 271.35M | -4.27% | 257,851 | - |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 271.32M | -5.09% | 12,864 | 383.48K |
| 264 | AGEN | Agenus Inc. | 270.12M | -2.77% | 711,686 | 133.95M |
| 265 | NAUT | Nautilus Biotechnology, Inc. | 270.03M | -2.30% | 6,263,726 | 424.00K |
| 266 | KYTX | Kyverna Therapeutics, Inc. | 269.33M | -2.52% | 1,338,636 | - |
| 267 | AGMB | AgomAb Therapeutics NV | 268.40M | -3.02% | 179,863 | - |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 265.11M | 1.54% | 1,106,420 | 1.00 |
| 269 | PEPG | PepGen Inc. | 261.81M | -3.82% | 4,430,575 | - |
| 270 | OCGN | Ocugen, Inc. | 260.55M | 4.79% | 6,193,983 | 4.78M |
| 271 | ALT | Altimmune, Inc. | 258.80M | -5.67% | 4,058,919 | 26.00K |
| 272 | EIKN | Eikon Therapeutics, Inc. | 256.84M | -0.42% | 691,421 | - |
| 273 | SABS | SAB Biotherapeutics, Inc. | 253.15M | -3.44% | 874,033 | 114.70K |
| 274 | EDIT | Editas Medicine, Inc. | 253.12M | -4.09% | 2,680,546 | 49.83M |
| 275 | QTTB | Q32 Bio Inc. | 249.57M | -1.65% | 476,715 | 53.74M |
| 276 | TTRX | Turn Therapeutics Inc. | 247.49M | -6.31% | 82,771 | - |
| 277 | LXEO | Lexeo Therapeutics, Inc. | 245.04M | 0.34% | 1,800,333 | - |
| 278 | PLX | Protalix BioTherapeutics, Inc. | 244.52M | -5.23% | 1,232,199 | 84.69M |
| 279 | AUTL | Autolus Therapeutics plc | 241.65M | -7.38% | 3,898,407 | 137.43M |
| 280 | CUVL | Clinuvel Pharmaceuticals Limited | 239.54M | -1.91% | 6,068 | 65.05M |
| 281 | CAMP | Camp4 Therapeutics Corporation | 237.84M | -5.25% | 88,478 | 5.32M |
| 282 | SCTX | Scribe Therapeutics Inc. | 228.58M | -8.70% | 302,072 | 14.83M |
| 283 | ENTA | Enanta Pharmaceuticals, Inc. | 222.19M | -4.51% | 456,609 | 63.00M |
| 284 | IMRX | Immuneering Corporation | 218.90M | -2.03% | 1,455,092 | - |
| 285 | RCKT | Rocket Pharmaceuticals, Inc. | 217.74M | -7.58% | 2,898,415 | - |
| 286 | ALLO | Allogene Therapeutics, Inc. | 217.48M | -5.88% | 7,579,436 | 4.64M |
| 287 | KROS | Keros Therapeutics, Inc. | 217.44M | -2.72% | 208,641 | 40.76M |
| 288 | PYXS | Pyxis Oncology, Inc. | 216.49M | 7.74% | 3,054,515 | 11.04M |
| 289 | ARCT | Arcturus Therapeutics Holdings Inc. | 214.73M | -1.97% | 601,923 | 30.51M |
| 290 | IPSC | Century Therapeutics, Inc. | 211.56M | -11.74% | 916,611 | 109.16M |
| 291 | VNDA | Vanda Pharmaceuticals Inc. | 208.32M | -6.13% | 1,304,434 | 229.28M |
| 292 | FTH | Faeth Therapeutics, Inc. | 203.65M | -9.32% | 419,012 | - |
| 293 | BCYC | Bicycle Therapeutics plc | 203.27M | -4.92% | 1,023,517 | 83.53M |
| 294 | CABA | Cabaletta Bio, Inc. | 201.94M | -7.32% | 3,742,538 | - |
| 295 | DRUG | Bright Minds Biosciences Inc. | 199.73M | -1.45% | 165,908 | - |
| 296 | NGEN | NervGen Pharma Corp. | 198.38M | -3.91% | 666,824 | - |
| 297 | ACOG | Alpha Cognition Inc. | 198.37M | 1.69% | 269,671 | 20.20M |
| 298 | LCTX | Lineage Cell Therapeutics, Inc. | 196.95M | -5.87% | 2,039,603 | 10.84M |
| 299 | MDWD | MediWound Ltd. | 194.20M | 0.37% | 187,835 | 10.01M |
| 300 | ACIU | AC Immune SA | 193.88M | -8.45% | 298,382 | 23.75M |
| 301 | VTVT | vTv Therapeutics Inc. | 192.99M | -5.20% | 10,590 | 36.84M |
| 302 | ANTX | AN2 Therapeutics, Inc. | 192.75M | -2.68% | 332,633 | - |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 187.29M | 4.24% | 279,908 | 1.03M |
| 304 | ARTV | Artiva Biotherapeutics, Inc. | 186.85M | -1.31% | 1,775,377 | 251.00K |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 181.16M | -1.60% | 451,481 | 7.15M |
| 306 | SLGL | Sol-Gel Technologies Ltd. | 180.76M | 2.02% | 24,663 | 1.44M |
| 307 | VOGX | Vogenx, Inc. | 176.33M | -7.34% | 100,826 | - |
| 308 | CGEN | Compugen Ltd. | 174.29M | -2.13% | 188,219 | 75.93M |
| 309 | KRRO | Korro Bio, Inc. | 167.18M | -0.08% | 123,523 | 1.29M |
| 310 | TRDA | Entrada Therapeutics, Inc. | 158.80M | -6.25% | 347,920 | 3.98M |
| 311 | ORMP | Oramed Pharmaceuticals Inc. | 155.24M | -3.25% | 285,665 | 2.00M |
| 312 | IFRX | InflaRx N.V. | 153.26M | -4.59% | 472,105 | -38.53K |
| 313 | PALI | Palisade Bio, Inc. | 150.58M | -9.24% | 3,199,331 | 500.00K |
| 314 | ELDN | Eledon Pharmaceuticals, Inc. | 150.48M | -6.32% | 1,294,684 | - |
| 315 | RNA | Atrium Therapeutics, Inc. | 149.27M | -0.86% | 319,585 | 38.82M |
| 316 | YARW | Yarrow Bioscience, Inc. | 148.01M | -9.35% | 117,070 | - |
| 317 | VRXA | Veraxa Biotech AG | 147.06M | 0.97% | 114,618 | 29.54K |
| 318 | PRQR | ProQR Therapeutics N.V. | 146.98M | -0.95% | 920,549 | 23.46M |
| 319 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 145.25M | -2.69% | 450,949 | - |
| 320 | STRO | Sutro Biopharma, Inc. | 142.77M | -1.38% | 275,895 | 45.11M |
| 321 | TARA | Protara Therapeutics, Inc. | 140.38M | -5.00% | 1,066,659 | - |
| 322 | ABEO | Abeona Therapeutics Inc. | 138.30M | -1.22% | 4,719,266 | 39.01M |
| 323 | ALXO | ALX Oncology Holdings Inc. | 137.03M | 3.92% | 997,706 | - |
| 324 | ZNTL | Zentalis Pharmaceuticals, Inc. | 133.64M | 0.00% | 1,462,135 | 26.87M |
| 325 | PYPD | PolyPid Ltd. | 129.29M | -6.56% | 456,265 | - |
| 326 | SION | Sionna Therapeutics, Inc. | 127.79M | -4.88% | 555,657 | - |
| 327 | MGNX | MacroGenics, Inc. | 125.26M | -1.01% | 1,524,423 | 140.81M |
| 328 | CMPX | Compass Therapeutics, Inc. | 123.94M | 1.43% | 1,823,573 | 850.00K |
| 329 | HUMA | Humacyte, Inc. | 123.73M | -17.90% | 5,790,897 | 2.40M |
| 330 | MSLE | Satellos Bioscience Inc. | 122.07M | -2.07% | 113,907 | - |
| 331 | IVVD | Invivyd, Inc. | 122.01M | -7.45% | 5,315,017 | 60.69M |
| 332 | ADAG | Adagene Inc. | 118.17M | -12.44% | 1,371,420 | 9.29M |
| 333 | ENGN | enGene Therapeutics Inc. | 116.61M | -1.14% | 556,716 | - |
| 334 | ARMP | Armata Pharmaceuticals, Inc. | 112.69M | 1.68% | 85,853 | 7.56M |
| 335 | FATE | Fate Therapeutics, Inc. | 111.72M | -9.01% | 3,705,375 | 4.75M |
| 336 | CDXS | Codexis, Inc. | 110.69M | -3.81% | 2,066,740 | 88.34M |
| 337 | OKUR | OnKure Therapeutics, Inc. | 109.36M | -2.17% | 195,211 | - |
| 338 | SPRB | Spruce Biosciences, Inc. | 109.21M | -6.15% | 108,258 | 697.00K |
| 339 | MENS | Jyong Biotech Ltd. | 107.64M | -17.14% | 90,894 | - |
| 340 | FHTX | Foghorn Therapeutics Inc. | 103.14M | -3.37% | 919,929 | 112.13M |
| 341 | VANI | Vivani Medical, Inc. | 102.83M | 4.59% | 448,602 | - |
| 342 | NERV | Minerva Neurosciences, Inc. | 99.67M | -5.66% | 137,661 | - |
| 343 | ICCC | ImmuCell Corporation | 99.28M | -2.24% | 18,748 | 33.21M |
| 344 | CNTN | Canton Strategic Holdings, Inc. | 98.78M | -1.63% | 877,598 | 4.47M |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 97.77M | -5.10% | 1,362,292 | - |
| 346 | GNLX | Genelux Corporation | 97.24M | -4.82% | 315,921 | 8.00K |
| 347 | NBP | NovaBridge Biosciences | 96.28M | -5.66% | 991,514 | - |
| 348 | PDSB | PDS Biotechnology Corporation | 95.39M | -3.70% | 2,903,438 | - |
| 349 | IMUX | Immunic, Inc. | 95.37M | -5.41% | 296,532 | - |
| 350 | VYGR | Voyager Therapeutics, Inc. | 95.21M | -4.97% | 639,240 | 25.11M |
| 351 | OTLK | Outlook Therapeutics, Inc. | 94.94M | -2.74% | 5,193,932 | -1.16M |
| 352 | LENZ | LENZ Therapeutics, Inc. | 93.16M | -11.23% | 951,763 | 12.36M |
| 353 | NRXP | NRx Pharmaceuticals, Inc. | 93.02M | -15.69% | 1,475,335 | 4.31M |
| 354 | CBUS | Cibus, Inc. | 92.48M | -1.63% | 65,913 | 4.53M |
| 355 | ZURA | Zura Bio Limited | 89.63M | -2.30% | 4,773,858 | - |
| 356 | MOLN | Molecular Partners AG | 88.72M | -5.25% | 928 | 856.30K |
| 357 | RTSN | Retension Pharmaceuticals, Inc. | 87.57M | -19.22% | 162,742 | - |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 87.48M | -9.48% | 225,071 | 39.99K |
| 359 | EQ | Equillium, Inc. | 87.26M | -5.36% | 570,783 | 4.39M |
| 360 | UPB | Upstream Bio, Inc. | 87.15M | -20.50% | 1,386,138 | 2.87M |
| 361 | IPHA | Innate Pharma S.A. | 85.43M | -8.14% | 18,034 | 11.21M |
| 362 | ANIX | Anixa Biosciences, Inc. | 84.82M | -6.15% | 355,032 | - |
| 363 | RLYB | Rallybio Corporation | 83.29M | -0.32% | 55,493 | 434.00K |
| 364 | NKTX | Nkarta, Inc. | 81.38M | 1.34% | 1,603,335 | - |
| 365 | HURA | TuHURA Biosciences, Inc. | 79.66M | -8.09% | 523,819 | - |
| 366 | TLSA | Tiziana Life Sciences Ltd | 79.45M | -8.14% | 231,843 | - |
| 367 | SEER | Seer, Inc. | 75.91M | -1.81% | 130,275 | 14.08M |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 75.28M | -5.76% | 673,319 | 70.00M |
| 369 | RANI | Rani Therapeutics Holdings, Inc. | 71.28M | -11.97% | 459,003 | 6.58M |
| 370 | COYA | Coya Therapeutics, Inc. | 69.20M | -1.01% | 138,271 | 4.69M |
| 371 | MAIA | MAIA Biotechnology, Inc. | 68.54M | -2.63% | 508,769 | - |
| 372 | CLLS | Cellectis S.A. | 68.02M | -6.39% | 52,626 | 32.10M |
| 373 | KZIA | Kazia Therapeutics Limited | 67.42M | -8.38% | 732,076 | 1.32M |
| 374 | MNOV | MediciNova, Inc. | 67.11M | 3.15% | 48,962 | 935.72K |
| 375 | TENX | Tenax Therapeutics, Inc. | 67.01M | -10.07% | 2,284,852 | - |
| 376 | CRDF | Cardiff Oncology, Inc. | 66.34M | -4.46% | 520,960 | 559.00K |
| 377 | PLYX | Polaryx Therapeutics, Inc. | 66.30M | -11.92% | 49,399 | - |
| 378 | PMVP | PMV Pharmaceuticals, Inc. | 66.17M | -33.13% | 4,821,937 | - |
| 379 | CING | Cingulate Inc. | 65.58M | -14.26% | 976,208 | - |
| 380 | GOSS | Gossamer Bio, Inc. | 65.57M | -4.54% | 191,432 | 78.42M |
| 381 | TNYA | Tenaya Therapeutics, Inc. | 65.32M | -3.99% | 4,372,435 | 3.03M |
| 382 | ATRA | Atara Biotherapeutics, Inc. | 64.49M | -0.16% | 36,417 | 3.97M |
| 383 | FBIO | Fortress Biotech, Inc. | 63.37M | 7.34% | 739,058 | 69.99M |
| 384 | NMRA | Neumora Therapeutics, Inc. | 63.01M | -3.78% | 1,060,850 | - |
| 385 | CSBR | Champions Oncology, Inc. | 60.41M | -1.36% | 8,891 | 60.66M |
| 386 | NRXS | NeurAxis, Inc. | 59.90M | -6.22% | 151,816 | 6.53M |
| 387 | NTRB | Nutriband Inc. | 59.81M | -1.60% | 7,005 | 1.62M |
| 388 | CHRS | Coherus Oncology, Inc. | 57.15M | -4.47% | 2,521,616 | 53.64M |
| 389 | IBIO | iBio, Inc. | 56.37M | -0.11% | 3,363,735 | 1.08M |
| 390 | OKYO | OKYO Pharma Limited | 56.15M | -7.76% | 76,391 | - |
| 391 | CGTX | Cognition Therapeutics, Inc. | 55.37M | -3.06% | 665,416 | - |
| 392 | AZR | Azora Therapeutics, Inc. | 55.00M | -0.52% | 41,825 | - |
| 393 | AVXL | Anavex Life Sciences Corp. | 54.83M | -11.39% | 1,636,295 | - |
| 394 | BOLD | Boundless Bio, Inc. | 54.78M | -2.52% | 147,867 | - |
| 395 | NORD | Nordicus Partners Corporation | 54.61M | -4.44% | 4,649 | - |
| 396 | XLO | Xilio Therapeutics, Inc. | 53.40M | 0.67% | 20,100 | 55.01M |
| 397 | XBIT | XBiotech Inc. | 52.74M | 2.98% | 140,203 | - |
| 398 | MIST | Milestone Pharmaceuticals Inc. | 52.29M | -7.06% | 1,530,744 | 5.31M |
| 399 | ALDX | Aldeyra Therapeutics, Inc. | 50.70M | 16.39% | 2,509,456 | - |
| 400 | CLNN | Clene Inc. | 50.69M | 0.57% | 144,071 | 238.00K |
| 401 | ACRV | Acrivon Therapeutics, Inc. | 49.28M | -17.86% | 1,294,439 | - |
| 402 | HRTX | Heron Therapeutics, Inc. | 48.04M | -4.39% | 1,760,890 | 148.22M |
| 403 | CNXU | Conexeu Sciences Inc. | 47.79M | -25.48% | 683,607 | - |
| 404 | VRCA | Verrica Pharmaceuticals Inc. | 47.07M | -5.03% | 127,028 | 22.89M |
| 405 | TNXP | Tonix Pharmaceuticals Holding Corp. | 46.25M | -6.67% | 1,263,290 | 43.05M |
| 406 | HOWL | Werewolf Therapeutics, Inc. | 46.00M | -3.97% | 373,982 | 21.00M |
| 407 | RNXT | RenovoRx, Inc. | 45.45M | -10.29% | 477,430 | 2.78M |
| 408 | ONCY | Oncolytics Biotech Inc. | 44.64M | -10.37% | 1,108,668 | - |
| 409 | GANX | Gain Therapeutics, Inc. | 44.50M | -4.82% | 585,936 | - |
| 410 | IMA | ImageneBio, Inc. | 44.50M | -1.51% | 44,332 | 800.00K |
| 411 | ANVS | Annovis Bio, Inc. | 44.12M | -4.96% | 1,439,169 | - |
| 412 | SPRO | Spero Therapeutics, Inc. | 43.23M | -10.20% | 425,335 | 41.56M |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 43.15M | 0.38% | 14,980 | - |
| 414 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 42.45M | -15.40% | 1,382,701 | - |
| 415 | BMEA | Biomea Fusion, Inc. | 41.75M | -2.38% | 1,133,548 | - |
| 416 | MREO | Mereo BioPharma Group plc | 41.52M | -5.45% | 1,086,184 | 800.00K |
| 417 | INKT | MiNK Therapeutics, Inc. | 41.17M | -6.85% | 19,030 | 200.00K |
| 418 | ELTX | Elicio Therapeutics, Inc. | 41.05M | -3.33% | 231,624 | - |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 39.57M | -2.36% | 646,483 | 100.00K |
| 420 | ALPS | Alps Group Inc | 38.27M | -3.36% | 49,175 | 3.74M |
| 421 | CNTB | Connect Biopharma Holdings Limited | 38.05M | -6.08% | 365,982 | 3.67M |
| 422 | OSTX | OS Therapies Incorporated | 37.10M | -2.12% | 489,728 | - |
| 423 | PLRX | Pliant Therapeutics, Inc. | 36.89M | -4.02% | 933,400 | - |
| 424 | GRCE | Grace Therapeutics, Inc. | 35.97M | -1.16% | 154,968 | - |
| 425 | TIL | Instil Bio, Inc. | 35.47M | -5.77% | 64,336 | - |
| 426 | APLM | Apollomics, Inc. | 34.41M | -6.92% | 4,044 | 445.00K |
| 427 | VERU | Veru Inc. | 33.08M | -8.06% | 247,780 | 16.89M |
| 428 | ATNM | Actinium Pharmaceuticals, Inc. | 33.01M | -1.87% | 280,910 | 35.00M |
| 429 | HYFT | MindWalk Holdings Corp. | 32.24M | -14.27% | 693,949 | 11.57M |
| 430 | FLNA | Filana Therapeutics, Inc. | 32.24M | 14.52% | 1,332,406 | - |
| 431 | HYPD | Hyperion DeFi, Inc. | 32.12M | -11.11% | 304,360 | 1.91M |
| 432 | CRBU | Caribou Biosciences, Inc. | 30.71M | -8.44% | 3,256,026 | 9.44M |
| 433 | KLRS | Kalaris Therapeutics, Inc. | 30.47M | -5.19% | 37,986 | - |
| 434 | CUE | Cue Biopharma, Inc. | 30.15M | -7.78% | 1,262,551 | 35.64M |
| 435 | SER | Serina Therapeutics, Inc. | 29.76M | -6.67% | 62,352 | 125.00K |
| 436 | NXTC | NextCure, Inc. | 29.53M | -4.87% | 30,875 | - |
| 437 | NNVC | NanoViricides, Inc. | 29.10M | -2.56% | 106,792 | - |
| 438 | RNTX | Rein Therapeutics Inc. | 29.06M | -8.38% | 668,747 | - |
| 439 | PMN | ProMIS Neurosciences, Inc. | 28.43M | -1.56% | 109,911 | - |
| 440 | ATHE | Alterity Therapeutics Limited | 28.16M | -8.16% | 20,233 | 2.50M |
| 441 | EDSA | Edesa Biotech, Inc. | 27.02M | -8.05% | 121,173 | - |
| 442 | EXOZ | eXoZymes, Inc. | 26.96M | -14.05% | 10,823 | -700.00 |
| 443 | BCTX | BriaCell Therapeutics Corp. | 26.83M | -3.16% | 109,662 | - |
| 444 | TELO | Telomir Pharmaceuticals, Inc. | 26.82M | -17.24% | 255,911 | - |
| 445 | EYPT | EyePoint, Inc. | 26.65M | -11.36% | 4,938,937 | 2.58M |
| 446 | INMB | INmune Bio Inc. | 25.60M | -7.50% | 327,146 | 50.00K |
| 447 | PTHS | Pelthos Therapeutics Inc. | 25.08M | -8.73% | 63,963 | 51.29M |
| 448 | LITS | Lite Strategy, Inc. | 23.99M | -4.03% | 178,450 | - |
| 449 | IMMP | Immutep Limited | 23.50M | -9.06% | 44,748 | 13.79M |
| 450 | ACET | Adicet Bio, Inc. | 23.04M | -13.01% | 765,201 | - |
| 451 | ABVC | ABVC BioPharma, Inc. | 22.74M | -1.56% | 39,055 | 797.92K |
| 452 | PLRZ | Polyrizon Ltd. | 22.61M | -8.46% | 4,851 | - |
| 453 | GRDX | GridAI Technologies Corp. | 22.38M | -8.41% | 125,138 | - |
| 454 | CRVO | CervoMed Inc. | 22.09M | 9.77% | 1,198,338 | 8.73K |
| 455 | MGX | Metagenomi Therapeutics, Inc. | 21.36M | -7.95% | 274,375 | 7.09M |
| 456 | CVM | CEL-SCI Corporation | 21.28M | -17.69% | 880,307 | - |
| 457 | EVAX | Evaxion A/S | 20.75M | 10.84% | 104,032 | 7.49M |
| 458 | AARD | Aardvark Therapeutics, Inc. | 20.19M | -7.74% | 241,067 | - |
| 459 | RNAZ | TransCode Therapeutics, Inc. | 20.07M | -10.77% | 60,671 | - |
| 460 | IGC | IGC Pharma, Inc. | 19.60M | -8.70% | 514,211 | 1.11M |
| 461 | LONA | LeonaBio, Inc. | 19.03M | -17.89% | 68,874 | - |
| 462 | COCP | Cocrystal Pharma, Inc. | 18.30M | -2.05% | 42,947 | 435.00K |
| 463 | MRKR | Marker Therapeutics, Inc. | 18.17M | -17.42% | 1,966,242 | 2.31M |
| 464 | AKTX | Akari Therapeutics, Plc | 16.41M | 7.00% | 15,265 | - |
| 465 | LPCN | Lipocine Inc. | 16.39M | -1.33% | 219,927 | 3.74M |
| 466 | KTTA | Pasithea Therapeutics Corp. | 16.00M | -0.48% | 100,722 | - |
| 467 | ATOS | Atossa Therapeutics, Inc. | 15.92M | -8.86% | 48,911 | - |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.76M | -2.35% | 11,249 | - |
| 469 | CELU | Celularity Inc. | 15.02M | -1.05% | 295,865 | 18.67M |
| 470 | CNTX | Context Therapeutics Inc. | 14.70M | -5.10% | 1,115,283 | - |
| 471 | NCEL | NewcelX Ltd. | 14.67M | -5.58% | 5,608 | - |
| 472 | ESLA | Estrella Immunopharma, Inc. | 13.96M | -5.70% | 251,677 | - |
| 473 | CTXR | Citius Pharmaceuticals, Inc. | 13.96M | 2.27% | 183,702 | 7.11M |
| 474 | BYSI | BeyondSpring Inc. | 13.57M | -24.49% | 70,953 | 1.88M |
| 475 | PLUR | Pluri Inc. | 13.51M | -3.07% | 25,866 | 1.46M |
| 476 | ABOS | Acumen Pharmaceuticals, Inc. | 13.49M | -3.52% | 2,713,584 | - |
| 477 | TVRD | Tvardi Therapeutics, Inc. | 13.20M | 4.57% | 161,559 | - |
| 478 | BOLT | Bolt Biotherapeutics, Inc. | 12.80M | -2.96% | 60,409 | 4.70M |
| 479 | NEUP | Neuphoria Therapeutics Inc. | 12.72M | 1.29% | 55,960 | 1.17M |
| 480 | MCRB | Seres Therapeutics, Inc. | 12.64M | -6.77% | 57,062 | 2.13M |
| 481 | PASG | Passage Bio, Inc. | 12.61M | 8.59% | 27,965 | - |
| 482 | ALLR | Allarity Therapeutics, Inc. | 12.49M | -9.25% | 306,388 | 350.00K |
| 483 | ACTU | Actuate Therapeutics, Inc. | 12.39M | 5.38% | 646,643 | - |
| 484 | BSEM | BioStem Technologies, Inc. | 12.18M | -10.23% | 254,190 | 31.75M |
| 485 | BCDA | BioCardia, Inc. | 11.88M | 1.60% | 352,429 | 3.00K |
| 486 | RADX | Radiopharm Theranostics Limited | 11.53M | -6.33% | 12,725 | 8.90M |
| 487 | PBM | Psyence Biomedical Ltd. | 11.33M | 3.85% | 32,642 | - |
| 488 | QNTM | Quantum BioPharma Ltd. | 11.30M | -9.15% | 140,252 | - |
| 489 | GUTS | Fractyl Health, Inc. | 10.88M | -14.16% | 337,175 | 3.00K |
| 490 | CMMB | Chemomab Therapeutics Ltd. | 10.70M | 4.39% | 70,742 | - |
| 491 | PPBT | Purple Biotech Ltd | 10.49M | -0.33% | 21,668 | - |
| 492 | DYAI | Dyadic International, Inc. | 10.46M | -7.66% | 85,345 | 3.09M |
| 493 | TCRX | TScan Therapeutics, Inc. | 9.89M | 2.24% | 391,636 | 5.19M |
| 494 | ATYR | aTyr Pharma, Inc. | 9.74M | 3.52% | 91,027 | 190.00K |
| 495 | JSPR | Jasper Therapeutics, Inc. | 9.64M | -19.16% | 11,716 | - |
| 496 | GDTC | CytoMed Therapeutics Limited | 9.01M | -2.33% | 15,478 | 609.73K |
| 497 | CALC | CalciMedica, Inc. | 8.69M | 7.69% | 91,265 | - |
| 498 | BIVI | BioVie Inc. | 8.58M | -12.07% | 399,581 | - |
| 499 | LEXX | Lexaria Bioscience Corp. | 8.49M | -10.24% | 32,860 | 194.00K |
| 500 | HIND | Vyome Holdings, Inc. | 8.42M | -17.24% | 34,951 | 153.10K |